2 33 Cardiovascular risk factors are related to distinct white matter hyperintensity MRI phenotypes 18. Gouw AA, Seewann A, Van Der Flier WM, Barkhof F, Rozemuller AM, Scheltens P et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011; 82: 126–135. 19. Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: Relative importance of vascular risk factors in nondemented elderly people. Radiology 2005; 237: 251–257. 20. Saczynski JS, Siggurdsson S, Jonsson P V, Eiriksdottir G, Olafsdottir E, Kjartansson O et al. Glycemic Status and Brain Injury in Older Individuals The Age Gene/Environment Susceptibility-Reykjavik Study. 2009. doi:10.2337/dc08-2300. 21. Den Heijer T, Vermeer SE, Van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003; 46: 1604–1610. 22. Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K et al. Magnetic Resonance Imaging of the Brain in Diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004; 53: 687–692. 23. Wang D-Q, Wang L, Wei M-M, Xia X-S, Tian X-L, Cui X-H et al. Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review. Front Endocrinol (Lausanne) 2020; 0: 998. 24. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a populationbased study: The Rotterdam study. Neurology 1994; 44: 1246–1252. 25. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S et al. Hyperlipidemia and Reduced White Matter Hyperintensity Volume in Patients with Ischemic Stroke. Stroke 2010; 41: 437–442. 26. Ferguson AC, Tank R, Lyall LM, Ward J, Welsh P, Celis-Morales C et al. Association of SBP and BMI with cognitive and structural brain phenotypes in UK Biobank. J Hypertens 2020; 38: 2482–2489. 27. Morys F, Dadar M, Dagher A. Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline. J Clin Endocrinol Metab 2021. doi:10.1210/clinem/dgab135. 28. Lampe L, Zhang R, Beyer F, Huhn S, Kharabian Masouleh S, Preusser S et al. Visceral obesity relates to deep white matter hyperintensities via inflammation. Ann Neurol 2019; 85: 194–203. 29. Wardlaw JM, Valdés Hernández MC, Muñoz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015; 4: 001140. 30. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008; 71: 804–811. 31. Shim YS, Yang D-W, Roe CM, Coats MA, Benzinger TL, Xiong C et al. Pathological Correlates of White Matter Hyperintensities on MRI. Dement Geriatr Cogn Disord 2015; 39: 92.
RkJQdWJsaXNoZXIy MTk4NDMw